Evidence map›Paper›PMID 41465291›Full record

ReviewInternational journal of molecular sciences2025

Isosorbide Diesters: Mechanistic Insights and Therapeutic Applications in Skin and Neuroinflammatory Disorders.

Ratan K Chaudhuri, Thomas A Meyer

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ratan K ChaudhuriCuralysMD Dermaceuticals & Sytheon (Now Part of Hallstar), 10 Waterview Blvd, Parsippany, NJ 07054, USA.ORCID 0000-0001-5676-9933
Thomas A MeyerMeyer Sun and Skin Care Consultancy, Memphis, TN 38139, USA.ORCID 0009-0004-3290-2399

Funding

Hallstar Beauty (United States) None
6 · The paper itself

Abstract

Isosorbide fatty acid diesters constitute a novel class of bioactive compounds with emerging therapeutic applications in inflammatory and barrier-compromised disorders. Among them, isosorbide dicaprylate (IDC) and isosorbide di-linoleate/oleate (IDL) synergistically strengthen epidermal barrier integrity, enhance stratum corneum hydration, regulate keratinocyte differentiation, suppress proinflammatory signaling, and beneficially modulate the skin microbiome. Randomized, double-blind clinical trials in both pediatric and adult populations with atopic dermatitis (AD) demonstrate that topical IDC + IDL formulations significantly reduce pruritus, corticosteroid dependence, and

Indexed as

Anti-Inflammatory AgentsEstersIsosorbideNeuroinflammatory DiseasesSkin DiseasesAnimalsHumansSkinAnti-Inflammatory AgentsEstersIsosorbideanti-inflammatory activityatopic dermatitisepidermal barrier repairisosorbide fatty acid diestersmultiple sclerosispsoriasisskin hydrationskin microbiome modulation

Identifiers

PMID41465291
PMCPMC12732906

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.